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Abstract Ammodytoxin is a presynaptically neurotoxic (L-neu-
rotoxic) snake venom secretory phospholipase A2 (sPLA2). We
detected a 25 kDa protein which binds the toxin with very high
a⁄nity (R25) in porcine cerebral cortex [Vuc›emilo et al., Bio-
chem. Biophys. Res. Commun. 251 (1998) 209^212]. Here we
show that R25 is an integral membrane protein with intracellu-
lar localisation. It is the ¢rst sPLA2 receptor known to date
that localises to intracellular membranes. Centrifugation on su-
crose gradients was used to fractionate porcine cerebral cortex.
The subcellular composition of the fractions was determined by
following the distribution of organelle-speci¢c markers. The dis-
tribution of R25 in the fractions matched the distribution of the
mitochondrial marker succinate dehydrogenase, but not the
markers for plasma membrane, lysosomes, endoplasmic reticu-
lum, synaptic and secretory vesicles. R25 most likely resides in
mitochondria, which are known to be targets for sPLA2 neuro-
toxins in the nerve ending and are potentially implicated in the
process of L-neurotoxicity.
5 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Secretory phospholipases A2 (sPLA2s) catalyse the hydro-
lysis of the ester bond at the sn-2 position of glycerophospho-
lipids, liberating free fatty acids and lysophospholipids. To be
catalytically active, these enzymes require Ca2þ ions. They
form a family of structurally related, 13^18 kDa disulphide-
rich enzymes which further divides into eight groups (G), in-
cluding GI, GII, GIII, GV, GIX, GX, GXI and GXII [1,2].
sPLA2s are widely spread enzymes. They have been found in
di¡erent mammalian tissues [3] and as components of many
animal venoms [4]. Besides being involved in the digestion of
phospholipids in dietary food and the production of diverse
lipid mediators, sPLA2s have been found to play an important
role in the antibacterial defence, exocytosis, anticoagulation,
in£ammation, ischemia, atherosclerosis and cancer [3]. In ad-
dition, some venom sPLA2s evolved neurotoxic, myotoxic,
cardiotoxic and other pharmacological e¡ects [4]. Many of
these e¡ects cannot be explained by the phospholipase activity
of sPLA2 alone, but rather involve the interaction of the en-
zyme with speci¢c binding proteins [5]. sPLA2-binding pro-
teins have been discovered in di¡erent tissues, and their num-
ber is gradually increasing. They include the plasma
membrane (PM)-localised M-type sPLA2 receptors (sPLA2Rs)
[6,7], glypican-I [8] and the voltage-dependent Kþ channel [9].
Pentraxins are soluble extracellular sPLA2-binding proteins
[10], whereas crocalbin and TCBP-49 reside in the lumen of
the endoplasmic reticulum (ER) [11,12]. Additionally, the cy-
tosolic calmodulin (CaM) and 14-3-3 proteins were also found
to bind to some sPLA2s [13,14]. sPLA2s can therefore act
extracellularly, or they can be internalised to reach their intra-
cellular targets. sPLA2s were found to be able to enter a
variety of cells. The distribution of sPLA2 in particular cell
types was demonstrated to be group-dependent, implying the
functional non-redundancy of sPLA2s [15]. Depending on the
type of cell and the group of sPLA2s, they were detected in
the perinuclear area, caveolae or lysosomes [8,16^23]. Exter-
nally added GIB sPLA2 was translocated to the nucleus of
proliferative UIII cells [24]. The mitochondrial localisation of
sPLA2 is controversial. GIIA sPLA2 was puri¢ed from rat
liver mitochondria [25], where it should reside at the contact
sites between the outer and the inner membrane [26]. Also,
mitochondria seem to be the target of GIIA sPLA2 at least in
mitochondrial permeability transition [27], cell death during
chemical hypoxia [28] and in the process of L-neurotoxicity
[29].
Ammodytoxin C (AtxC) is a presynaptically or L-neuro-
toxic GIIA sPLA2 from the venom of Vipera ammodytes am-
modytes. Investigating the molecular basis of its action, we
have detected a 25 kDa protein (R25) in porcine cerebral
cortex which binds AtxC with a high a⁄nity [30]. As we re-
port in this communication, R25 appears to be the ¢rst inte-
gral membrane sPLA2-binding protein located intracellularly.
Our data show that it co-localises with mitochondria.
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2. Materials and methods
2.1. Materials
AtxC was isolated as described in [31]. Protein molecular mass
standards were from Bio-Rad, Na125I (carrier-free) from New Eng-
land Nuclear, Triton X-100 from Roche Molecular Biochemicals, Brij
35 and Lubrol 17A17 from Serva, p-iodonitrotetrazolium violet from
Sigma and Z-Phe-Arg-AMCWHCl from Bachem. All other reagents
and chemicals were of analytical grade.
2.2. Radioiodination of AtxC and crotoxin
AtxC and crotoxin isoform CA2CBd were radioiodinated as de-
scribed in [32,33]. Radioactive toxins were identical to the native
toxins in enzymatic, neurotoxic and immunological properties and
were kept at 4‡C.
2.3. Fractionation of porcine cerebral cortex
Fresh porcine brains were obtained from a local slaughterhouse.
Until dissecting the cortex, the brains were kept on ice. The demyeli-
nated crude mitochondrial^synaptosomal fraction P2, which was used
in some experiments, was prepared as described in [34].
Fractionation of porcine cerebral cortex was performed essentially
following the procedure of Casado et al. [35]. Fresh porcine cerebral
cortex (10 g) was immersed in 100 ml bu¡er A (7 mM imidazole, pH
7.4, 0.32 M sucrose, 2 mM EDTA) to which protease inhibitors (31
Wg/ml benzamidine, 25 Wg/ml bacitracin, 2 Wg/ml soybean trypsin in-
hibitor, 1.4 Wg/ml pepstatin, 1 Wg/ml leupeptin, 0.1 mM PMSF) were
added immediately before use. The tissue was homogenised with a
Glas-Col Potter homogeniser (500 rpm, ¢ve strokes). The homogenate
was centrifuged for 10 min at 1000Ug. The resulting pellet was re-
suspended in 40 ml bu¡er A and centrifuged for 12 min at 1000Ug.
The pellet was resuspended in 38 ml bu¡er A and is referred to as the
nuclear fraction, P1. Both supernatants were pooled and centrifuged
for 20 min at 12 000Ug, the pellet resuspended in 40 ml bu¡er A and
centrifuged again using the same conditions. The pellet was ¢nally
resuspended in 20 ml bu¡er A to obtain the crude mitochondrial^
synaptosomal fraction, P2. To isolate the microsomal fraction, P3,
the two supernatants were pooled and ultracentrifuged for 90 min
at 105 000Ug and the pellet resuspended in 22 ml bu¡er A.
Fractions P1, P2 and P3 were further fractionated on three di¡erent
discontinuous sucrose density gradients in a swinging bucket rotor
(TST 28.38, Sorvall) for 120 min at 55 000Ug. Fraction P1 (19 ml)
was layered on 19 ml of 0.8 M sucrose. After the centrifugation two
fractions were obtained, P1a at the interphase and P1b as pellet.
Fraction P2 (10 ml) was layered on four 7 ml layers of 0.8, 1.0, 1.2
and 1.4 M sucrose (top to bottom). Five fractions were collected, four
at the interphases (P2a^P2d) and the pellet (P2e). Fraction P3 (11 ml)
was layered on three 9 ml layers of 0.8, 1.0 and 1.2 M sucrose (top to
bottom). Following the centrifugation three fractions were obtained at
the interphases (P3a^P3c) and the pellet (P3d).
2.4. Determination of protein concentration in fractions
Protein concentration was measured by the method of Markwell et
al. [36] using bovine serum albumin as a standard.
2.5. Determination of enzyme activities in fractions
NADPH: cytochrome c reductase (EC 1.6.2.4) activity was assayed
using the method of Masters et al. [37]. Cathepsin L (EC 3.4.22.15)
activity was determined by the method of Barret and Kirschke [38].
Succinate dehydrogenase (EC 1.3.99.1) activity was assayed by the
method of Morre [39] and Kþ-(p-nitrophenyl phosphatase) (EC
3.1.3.41) activity by the method of Marcheselli et al. [40].
2.6. Solubilisation of membrane proteins
Fractions of porcine cerebral cortex were extracted for 1 h at 4‡C
by gentle agitation in 75 mM HEPES, pH 8.2, containing 150 mM
NaCl, 2.5 mM CaCl2, and 2% (w/v) Triton X-100. The resulting
extracts were centrifuged for 1 h at 4‡C at 14 000 rpm in an Eppen-
dorf centrifuge (5417 R) and the supernatants collected. Di¡erent
concentrations of Triton X-100 and NaCl were tested for their ability
to solubilise the AtxC-binding proteins.
2.7. Covalent binding of 125I-AtxC to solubilised AtxC-binding proteins
^ a⁄nity labeling
Extracts (2 mg protein/ml) were incubated for 30 min at room
temperature with 10 nM 125I-AtxC or 2.5 nM 125I-crotoxin in the
presence or absence of a 200-fold excess of unlabeled AtxC or crotox-
in, respectively. Disuccinimidyl suberate (DSS) was added to 100 WM
¢nal concentration and after 5 min the cross-linking reaction was
stopped by the addition of SDS^PAGE sample bu¡er. Samples
were analysed by SDS^PAGE, gels dried and autoradiographed at
370‡C using Kodak X-Omat AR ¢lms [34]. Autoradiographs were
quanti¢ed using QuantiScan (Biosoft).
2.8. Electron microscopy
Suspensions of membranes from the fractions were ¢xed with 1%
(v/v) paraformaldehyde and 0.05% (v/v) glutaraldehyde in 200 mM
phosphate bu¡er (pH 7.4) for 30 min, and post¢xed with 0.1% (w/v)
OsO4 for 10 min at room temperature. The membranes were centri-
fuged for 5 min and then embedded in 2% (w/v) Agar Noble (Difco,
USA). After solidation the embedded membranes were cut to small
pieces and transferred into Eppendorf tubes. All the following steps
were done on an ice bath. The membranes were dehydrated in a
Fig. 1. AtxC-binding proteins in porcine cerebral cortex are integral
membrane proteins. The demyelinated P2 membranes of porcine ce-
rebral cortex were extracted in high-ionic-strength bu¡ers and bu¡-
ers containing the noted concentration of detergent Triton X-100.
The extracts were a⁄nity-labeled using (A) 125I-AtxC or (B) 125I-
crotoxin. Samples (100 Wg of protein/lane) were analysed by SDS^
PAGE, gels dried and autoradiographed. The positions of the spe-
ci¢c adducts are indicated on both autoradiograms. For experimen-
tal details, see Section 2.
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graded series of ethanol (30, 50, 70, 90, 100% (v/v) twice; 5 min each
step), transferred into a mixture of the acrylic resin LR White (SPI,
USA) and ethanol (100%) (v/v 1:1) for 30 min, followed by an in-
cubation with pure resin for another 30 min. After an additional
change the membranes were left in the resin overnight, transferred
to the capsules and polymerised at 50‡C for 2 days. Ultrathin sections
were cut with a diamond knife and mounted on copper grids with
formvar as supporting ¢lm, stained with uranyl acetate and lead cit-
rate and examined in an electron microscope (Jeol JEM 1200EXII).
3. Results
3.1. R25 is an integral membrane protein
As shown in Fig. 1A, neither 0.3 M NaCl nor 1 M NaCl in
the extraction bu¡er released the AtxC-binding protein of 25
kDa (R25) from the demyelinated P2 fraction of the porcine
cerebral cortex. The same was true for R180, which is an
M-type sPLA2R that resides in the plasma membrane [7].
Using the same extraction procedure, crocalbin, a crotoxin-
binding protein in the lumen of ER, was released from the P2
membrane preparation already with 0.3 M NaCl (Fig. 1B).
Increasing the concentration of the detergent Triton X-100 in
the extraction bu¡er, the lowest concentration to fully solu-
bilise R25 from the membranes was determined to be 1.5%
(w/v), two times higher than that su⁄cient to optimally
solubilise the membrane spanning R180. According to its
extraction characteristics, we conclude that R25 is an integral
membrane protein. To check the possibility of glycosylphos-
phatidylinositol (GPI) anchoring of R25 into the PM, the P2
membranes were treated with phosphatidylinositol-phospholi-
pase C (PI-PLC), which cuts the GPI-proteins free from their
membrane anchors. R25 was not removed from the mem-
branes by this treatment (data not shown).
3.2. Subcellular fractionation of the porcine cerebral cortex and
characterisation of the fractions
The porcine cerebral cortex homogenate was separated by
di¡erential centrifugation into three crude fractions: P1 (nu-
clear fraction), P2 (crude mitochondrial^synaptosomal frac-
tion) and P3 (microsomal fraction). Using discontinuous su-
crose gradients, these crude fractions were further fractionated
to obtain 11 fractions [35]. The bulk of the proteins was found
in the fraction P1b (54% of the total), followed by the frac-
tions P2c and P1a (21% and 11% of the total protein, respec-
tively).
To determine their subcellular composition, the organelle-
speci¢c markers were quanti¢ed in each of the isolated
fractions. The activities of the following enzymes were mea-
sured: cathepsin L as a lysosome-speci¢c enzyme (Fig. 2A),
NADPH:cytochrome c reductase as an ER-speci¢c enzyme
(Fig. 2B), succinate dehydrogenase as a mitochondrion-specif-
ic enzyme (Fig. 2C), and Kþ-(p-nitrophenyl phosphatase) as a
PM-speci¢c enzyme (Fig. 2D). The presence of PM in the
fractions was also quanti¢ed by 125I-AtxC a⁄nity labeling
of R180 (Figs. 3A). The distribution of synaptotagmin I
(p65), a protein speci¢cally located in synaptic and secretory
vesicles, was determined by immunoblotting.
Lysosomes were highly enriched in the fraction P2e
(Fig. 2A). The largest part of ER membranes was found in
the crude microsomal fraction, speci¢cally in the fraction P3a
(Fig. 2B). The distribution of crocalbin, an ER-residing cro-
Fig. 2. The distribution of organelle-speci¢c marker enzymes in fractions of porcine cerebral cortex. Each fraction was tested for the activity of
di¡erent marker enzymes. The value in a particular fraction is expressed relative to the sum of the enzyme activity in all fractions. Results are
means US.E.M. from eight experiments. For experimental details, see Section 2.
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toxin-binding protein [12], was revealed by 125I-crotoxin a⁄n-
ity labeling (data not shown). It con¢rmed the data obtained
by following the activity of NADPH:cytochrome c reductase.
Mitochondria concentrated mostly in the fraction P2d
(Fig. 2C). The highest content of PM was found in the frac-
tion P2b, followed by the microsomal fractions P3a and P3b
(Figs. 2D and 3A,B). Synaptic vesicles and secretory granules
were mostly present in the P2b fraction followed by P2a and
P2c, while in P2d only a very slight signal for synaptotagmin I
was detected (data not shown).
3.3. The distribution of AtxC-binding proteins in fractions
The distribution of speci¢c receptors for AtxC in the sub-
cellular fractions was determined using 125I-AtxC a⁄nity la-
beling. Two speci¢c adducts with the apparent molecular
masses of around 200 and 39 kDa were followed (Fig. 3A),
corresponding to two AtxC-receptors, R180 and R25, respec-
tively [30,34]. The quanti¢cation of the intensity of the speci¢c
bands is shown in Fig. 3B. R180, an M-type sPLA2R [7], was
found to be present in fractions enriched in PM (Fig. 2D), as
expected [41]. R25, however, fractionated in a completely dif-
ferent way, displaying a maximal enrichment in the fraction
P2d (Fig. 3). The comparison of the R25 distribution (Fig. 3)
with the marker enzyme pro¢les (Fig. 2A^E) shows a very
good match with the distribution of the mitochondrial marker
(Fig. 4) but not with the other markers, suggesting mitochon-
drial localisation of R25.
The fractions P2b and P2d, which contained the highest
amounts of R180 and R25, respectively, were also examined
under the electron microscope (Fig. 5). This morphological
analysis additionally con¢rmed that P2b contained mainly
PM fragments and that P2d contained mainly mitochondria.
4. Discussion
Studying the molecular mechanism of presynaptic neuro-
toxicity of Atx, a snake venom GIIA sPLA2, we detected a
25 kDa protein (R25) in porcine cerebral cortex which may be
involved in this process [30]. R25 binds AtxC and other re-
lated Atxs with a very high a⁄nity (dissociation constants Kd
in the nM range) [42^45]. The binding depends on the pres-
ence of Ca2þ or some other divalent ion, e.g. Sr2þ. There have
been some indications favouring the idea that R25 is an olig-
omeric protein with CaM as a toxin-binding subunit [13], but
other data suggest that the receptor is a monomeric protein
[44]. Supporting the latter, we demonstrate in this work that
R25 could not be released from the membranes under the
conditions which allow the release of peripherally bound pro-
teins. R25 therefore behaves as an integral membrane protein.
A preliminary study has shown that R25 does not co-localise
with a well-characterised receptor from the same tissue, an
Fig. 3. The distribution of R180 and R25 in fractions of porcine ce-
rebral cortex. A: The fractions were solubilised and a⁄nity-labeled
with 125I-AtxC. The two experiments, in absence (T) and in presence
(C) of an excess of unlabeled AtxC over 125I-AtxC, to determine the
positions of speci¢c adducts, were performed on the total P2 frac-
tion. Samples (100 Wg of protein/lane) were analysed by SDS^
PAGE. An autoradiogram of the gel is shown with the positions of
the speci¢c adducts indicated by arrows. For experimental details,
see Section 2. B: The intensities of the speci¢c bands were quanti-
¢ed and represented relative to the sum of intensities in all frac-
tions.
Fig. 4. The distribution of R25 and the mitochondrial marker succi-
nate dehydrogenase in fractions of porcine cerebral cortex are highly
correlated. The distributions of succinate dehydrogenase activity
(black line) and R25 (grey line) in fractions of porcine cerebral cor-
tex are given in arbitrary units, the ratio between the quantity in a
particular fraction and the quantity in the most enriched one.
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M-type sPLA2R, R180, which is a PM-spanning protein [46],
suggesting that R25 resides in some other part of the cell. The
detailed analysis of 11 subcellular fractions of the porcine ce-
rebral cortex homogenate in the present work con¢rms that
R25 is not a PM-residing protein and thus represents the ¢rst
intracellular integral membrane receptor for sPLA2. R25 was
mainly absent also from the fractions enriched in lysosomes,
ER, synaptic and secretory vesicles, dismissing the possibility
of its localisation in any of these membrane compartments.
However, it exhibited a distribution in the fractions that is
practically identical to the distribution of mitochondria. The
connection between mitochondria and sPLA2s is intriguing. It
has been observed that the PLA2 inhibitor tri£uoroperazine
inhibits a mitochondrial permeability transition, the state
when normally impermeant solutes cross the inner mitochon-
drial membrane at signi¢cant rates [27]. The e¡ect was as-
cribed to activation of phospholipolytic activity of sPLA2 in
mitochondria. Almost simultaneously, Aarsman et al. re-
ported the isolation of GIIA sPLA2 from the rat mitochon-
dria [25]. The enzyme was localised to the contact sites be-
tween mitochondrial inner and outer membrane [26].
Indication about the existence of a high-a⁄nity receptor for
GIIA sPLA2 in mitochondria that we present in this work
strengthens the belief that the link between GIIA sPLA2
and mitochondria is physiologically relevant. The interaction
of GIIA sPLA2 with the integral membrane R25 may prop-
erly position the enzyme in the organelle for its subsequent
enzymatic action. The direct targeting of de novo synthesised
GIIA sPLA2 to mitochondria is questionable. Namely, fol-
lowing the expression in BHK cells, the fusion between
EGFP (enhanced green £uorescent protein) and pro-GIIA
sPLA2 displayed a distribution pattern typical for a secretory
protein and the construct was not detected in mitochondria
[47]. The pathway from the outside of the cell into the mito-
chondria is even more di⁄cult to imagine; however, the fact is
that mitochondria are severely a¡ected upon intoxication of
the neurone by the presynaptically neurotoxic sPLA2s [29]. In
the case of Atx, the morphological changes of this organelle,
such as swelling and loss of the architecture of internal cristae
[48], resulting in mitochondrial uncoupling, may be related to
its interaction with R25.
In summary, we have demonstrated that a 25 kDa receptor
for Atx from porcine cerebral cortex represents (as far as we
know) the ¢rst intracellular integral membrane receptor for
GIIA sPLA2. R25 may be directing the distribution of the
sPLA2 enzyme in the target nerve cell. The receptor is most
likely located in mitochondria, the organelles that are strongly
disturbed by the action of sPLA2 neurotoxins, implying the
involvement of R25 in the process of L-neurotoxicity.
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